Alzheimer’s in China set to double.
The number of Alzheimer’s cases in China is set to double by 2030, according to independent analyst firm Datamonitor Healthcare.
Patient numbers currently stand at 6.7 million, but this will rise to 12.9 million in just 17 years.
The increase will be driven by China’s major cities, with urban areas set for an annual patient growth rate of 11%. This will see urban case numbers rise from 3.2 million in 2012 to over 9 million by 2030.
Conversely rural areas, which accounted for the majority of cases in 2012 (3.3 million), will only see a rise of 100,000 by 2030.
This means urban areas will account for 73% of all Alzheimer’s cases, up from just 49% in 2012.
Sabada Dube, lead epidemiologist at Datamonitor Healthcare, said: “This dramatic rise in patient population will be driven by growing and aging patient populations.
“Pharmaceutical companies that operate in this space should take note and adapt to what is a rapidly changing landscape in China.”
Additional forecasts, opinion and research from Datamonitor Healthcare is available at www.datamonitorhealthcare.com
Media Contact: Jonathan Saatchi @ MC2 | 0161 236 1352 | firstname.lastname@example.org
About Datamonitor Healthcare
Datamonitor Healthcare is a world-leading provider of premium business information, delivering research and analysis of all aspects of the healthcare sector.
Notes to editors
Whenever citing an analyst or quote, please remember to use ‘Datamonitor Healthcare’ rather than ‘Datamonitor’.
For descriptive purposes, Datamonitor Healthcare is a “leading research and consulting firm.”
Whenever possible, please hyperlink:
The Datamonitor Healthcare name to www.datamonitorhealthcare.com
Any reports used to the correct URL for that listing on our Report Store.
Please note that all supplied to the media, is owned exclusively by Datamonitor Healthcare, is governed by our terms and conditions, and therefore must be referenced.
Posted in Uncategorized.